Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor
1.7 هزار بار بازدید -
پارسال
-
Andrew Parsons presents the development
Andrew Parsons presents the development of a commercial manufacturing process for sotorasib, a first-in-class KRASG12C inhibitor.
Sponsored by Porton Pharma.
02:48 Introduction
03:21 Speaker Q&A
08:08 Presentation
43:27 Q&A
Presented on Apr. 19, 2023 as part of the Drug Hunter Flash Talk series.
Sign up for future sessions here: https://lu.ma/w1q906iz
Sponsored by Porton Pharma.
02:48 Introduction
03:21 Speaker Q&A
08:08 Presentation
43:27 Q&A
Presented on Apr. 19, 2023 as part of the Drug Hunter Flash Talk series.
Sign up for future sessions here: https://lu.ma/w1q906iz
پارسال
در تاریخ 1402/02/02 منتشر شده
است.
1,749
بـار بازدید شده